Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model
Purpose: Monoclonal antibodies (mAbs) are commonly administered by subcutaneous (SC) route. However, bioavailability is often reduced after SC administration. In addition, the sequential transfer of mAbs through the SC tissue and lymphatic system is not completely understood. Therefore, major object...
Saved in:
Main Authors: | Ninad Varkhede (Author), Laird Forrest (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice
by: Shufang Liu, et al.
Published: (2023) -
A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data
by: Hannah M. Jones, et al.
Published: (2019) -
Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim
by: Sumit Basu, et al.
Published: (2020) -
Effect of variable domain charge on in vitro and in vivo disposition of monoclonal antibodies
by: Shufang Liu, et al.
Published: (2021) -
A Physiologically‐Based Pharmacokinetic Model for the Prediction of "Half‐Life Extension" and "Catch and Release" Monoclonal Antibody Pharmacokinetics
by: Hannah M. Jones, et al.
Published: (2020)